CB1 siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemCB1 siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-39910
Gene Namecannabinoid receptor 1 (brain)
Specieshuman
NCBI Full Gene Namecannabinoid receptor 1
NCBI Gene AliasesCANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR
TypesiRNA/dsRNA
Quantity10 µM

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) "Human epithelial stem cell survival within their niche requires ""tonic"" cannabinoid receptor 1-signalling-Lessons from the hair follicle"Experimental dermatologyApril 1, 2021Sugawara K, Zákány N, Tiede S, Purba T, Harries M, Tsuruta D, Bíró T, Paus R.

(2) Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astrogliaNeurobiology of diseaseOctober 1, 2019Swinton MK, Carson A, Telese F, Sanchez AB, Soontornniyomkij B, Rad L, Batki I, Quintanilla B, Pérez-Santiago J, Achim CL, et al.the si-RNA-lipid complexes were added to the cells. CB1 siRNA (Santa Cruz Biotechnologies, cat. no. sc 39910) was used to knock down CB1 in the astrocytes. For controls, we used a control siRNA, (Santa Cruz Biotechnologies,

(3) Inhibitory effect of trans-caryophyllene (TC) on leukocyte-endothelial attachmentToxicology and applied pharmacologyAugust 15, 2017Zhang Z, Yang C, Dai X, Ao Y, Li Y.

(4) (R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motilityBiochemical pharmacologyFebruary 15, 2014Paul RK, Wnorowski A, Gonzalez-Mariscal I, Nayak SK, Pajak K, Moaddel R, Indig FE, Bernier M, Wainer IW.control for 48 h as indicated above. Each siRNA was a pool of 3 target-specific 20–25 nt siRNAs (CB1R, sc-39910; CB2R, sc-39912; Santa Cruz Biotechnology). 2.6 RNA Extraction, cDNA Synthesis, and Reverse Transcription-PCR

(5) Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situThe Journal of allergy and clinical immunologyJuly 1, 2013Sugawara K, Zákány N, Hundt T, Emelianov V, Tsuruta D, Schäfer C, Kloepper JE, Bíró T, Paus R.reader. 772 773 CB1 knock-down in situ 774 All reagents required for transfection (human CB1 siRNA (sc-39910), control 775 (scrambled, SCR) siRNA (sc-37007), siRNA transfection reagent (sc-29528) and 776 siRNA transfection Medium

(6) Anandamide induces matrix metalloproteinase-2 production through cannabinoid-1 receptor and transient receptor potential vanilloid-1 in human dental pulp cells in cultureJ EndodJune 1, 2012Miyashita K, Oyama T, Sakuta T, Tokuda M, Torii M.

(7) Endocannabinoids limit excessive mast cell maturation and activation in human skinThe Journal of allergy and clinical immunologyMarch 1, 2012Sugawara K, Bíró T, Tsuruta D, Tóth BI, Kromminga A, Zákány N, Zimmer A, Funk W, Gibbs BF, Zimmer A, et al.Methods). 196 197 CB1 knock-down in situ 198 All reagents required for transfection (human CB1 siRNA (sc-39910), control 199 (scrambled, SCR) siRNA (sc-37007), siRNA transfection reagent (sc-29528) 200 and siRNA transfection Medium

(8) AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin IIThe EMBO journalMay 3, 2011Rozenfeld R, Gupta A, Gagnidze K, Lim MP, Gomes I, Lee-Ramos D, Nieto N, Devi LA.

Be the First to Write a Review!

CB1 siRNA (h)

CB1 siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (8)

Reviews

CB1 siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map